Login to Your Account

Evotec regains U.K. chemistry business in $300M Aptuit buy

By Nuala Moran
Staff Writer

Monday, July 31, 2017

LONDON – Ten years after selling its U.K. chemistry development business for $64 million, Evotec AG is getting it back, as part of a $300 million acquisition of Aptuit Inc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription